Tag: Kallikrein

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Kallikrein

Analysts See $-0.54 EPS for KalVista Pharmaceuticals, Inc. (KALV); Applied Dna Sciences (APDN ...

Added to Collection on: 2019-11-23 22:47:18

Tags for this article:

Nucleic acids
Biotechnology
Applied DNA Sciences
DNA
Danaher Corporation
Kallikrein
Life Sciences
Companies
Biology
Applied Dna Sciences Inc.
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details
Takeda Submits New Drug Application in Japan for Lanadelumab as a Preventive Treatment for ...

Added to Collection on: 2021-03-12 06:56:15

Tags for this article:

Complement deficiency
Organ systems
Medical specialties
Clinical medicine
Lanadelumab
Hereditary angioedema
Angioedema
Kallikrein
C1-inhibitor
Shire
Hae
Japan
Takeda Pharmaceutical Company Limited

Click the tags to see associated articles and topics

View Article Details
Astria Therapeutics Announces FDA Clearance of IND Application for STAR-0215, a ...

Added to Collection on: 2022-07-29 13:55:53

Tags for this article:

Life Sciences
Complement deficiency
Organ systems
Medical specialties
Angioedema
Hereditary angioedema
Kinin–kallikrein system
Kallikrein
Biopharmaceutical
Hae
Lanadelumab

Click the tags to see associated articles and topics

View Article Details
Triveni Bio Raises $92M in Series A - FinSMEs

Added to Collection on: 2023-10-26 15:24:07

Tags for this article:

Tillman Gerngross
Atlas Venture
Atopy
Kallikrein
OrbiMed
Polaris Partners

Click the tags to see associated articles and topics

View Article Details
Triveni Bio: $115 Million (Series B) Closed To Advance Novel Antibody Treatments For I&I Disorders

Added to Collection on: 2024-10-04 20:36:35

Tags for this article:

Pancreas disorders
Hereditary pancreatitis
Pancreatitis
Trypsin 1
Triveni
Kallikrein
Goldman Sachs
Triveni Bio

Click the tags to see associated articles and topics

View Article Details